Pier 88 Investment Partners LLC Recursion Pharmaceuticals, Inc. Transaction History
Pier 88 Investment Partners LLC
- $75.6 Million
- Q4 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 161,730 shares of RXRX stock, worth $1.72 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
161,730
Previous 133,910
20.78%
Holding current value
$1.72 Million
Previous $882,000
23.92%
% of portfolio
1.45%
Previous 1.16%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
337Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$362 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$344 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$265 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$184 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$156 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.92B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...